Innovating and invigorating the clinical trial infrastructure for glomerular diseases

Affiliations

• ¹ Department of Pathology, Duke University, Raleigh-Durham, North Carolina, USA.
• ² Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.
• ³ Division of Nephrology, Mount Sinai School of Medicine, New York, New York, USA.
• ⁴ NephCure Kidney International, King of Prussia, Pennsylvania, USA.
• ⁵ Division of Nephrology, University of North Carolina and Covance, INC, Chapel Hill, North Carolina, USA.
• ⁶ Division of Pediatric Nephrology, University of Michigan, Ann Arbor, Michigan, USA.
• ⁷ Department of Medicine, University Medical Center, Hamburg-Eppendorf, Germany.
• ⁸ Innovation and Kidney Research, George Institute of Global Health, Newtown, New South Wales, Australia.
• ⁹ Division of Pediatric Nephrology, Cedars Sinai Medical Center, Los Angeles, California, USA.
• ¹⁰ Department of Pediatrics, University of Leuven, Brussels, Belgium.
• ¹¹ Nephrology, Kaiser Permanente, San Francisco, California, USA.
• ¹² Division of Nephrology, University of Minnesota, Minneapolis, Minnesota, USA.
• ¹³ Department of Pediatrics, University of Bristol, Bristol, UK.
• ¹⁴ Division of Nephrology, University of Washington, Seattle, Washington, USA.
• ¹⁵ Division of Cardiovascular and Renal Products, Food and Drug Administration, Silver Spring, Maryland, USA.
• ¹⁶ Divison of Pediatric Nephrology, Nationwide Children's Hospital, Columbus, Ohio, USA.
• ¹⁷ Division of Pediatric Nephrology, New York University, New York, New York, USA.
• ¹⁸ Nephrology Associates of Northern Illinois, Hinsdale, Illinois, USA.
• ¹⁹ Division of Nephrology and Dialysis, Bambino Gesu Children's Hospital, Rome, Italy.
• ²⁰ Division of Nephropathology, Arkana Labs, Little Rock, Arkansas, USA.
• ²¹ American Society of Nephrology, Washington, District of Columbia, USA.
• ²² Division of Nephrology, Ohio State University Wexner Medical Center, Columbus, Ohio, USA. Electronic address: Rovin.1@osu.edu.